BD-02 Blockade of the mechanistic target of rapamycin elicits rapid and lasting improvement of disease activity through restraining pro-inflammatory T cell lineage specification in patients with active SLE
Proceedings article published in 2018 by
Zhi-Wei Lai,
Ryan Kelly,
Thomas Winans,
Ivan Marchena,
Ashwini Shadakshari,
Julie Yu,
Maha Dawood,
Ricardo Garcia,
Hajra Tily,
Lisa Francis,
Stephen V. Faraone,
Paul E. Phillips,
Andras Perl
